MARKETING AND PROMOTION OF THE PRODUCT Sample Clauses

MARKETING AND PROMOTION OF THE PRODUCT. LIGAND shall control and be responsible for the content and format of the promotional campaign to be submitted to the FDA; provided that ELAN has the opportunity to review and provide input into such promotional campaign. LIGAND shall use reasonable endeavours to obtain approval by the FDA of the promotional campaign for the PRODUCT.
AutoNDA by SimpleDocs
MARKETING AND PROMOTION OF THE PRODUCT. Within 90 days after the filing of the REGULATORY APPLICATION for a PRODUCT in each country of the TERRITORY, GEMINI will outline to ELAN the structure of the promotional activities to be carried out by GEMINI for the period up to the first launch of such PRODUCT and for a period of 1 year thereafter. GEMINI shall both prior to and subsequent to the launch of a PRODUCT communicate with ELAN regarding its objectives for and performance of such PRODUCT in each country of the TERRITORY.
MARKETING AND PROMOTION OF THE PRODUCT. The Parties have established a Marketing Committee consisting of at least one representative from each Party who shall act as liaison between the Parties to ensure that Elan is up to date on the prevailing market conditions and Xxxxxx’x efforts at marketing and selling the Product. Xxxxxx shall continue to communicate with Elan regarding its objectives for and performance of the Product in the Territory. At such meetings, Xxxxxx shall report on the ongoing sales performance of the Product in the Territory, including marketing approaches, educational campaigns, promotional and advertising materials and campaigns, sales plans and results, performance against competitors, its objectives for the Product and its plans for the next year of this Agreement. In addition the Marketing Committee shall review the quarterly royalty statements and in particular the deductible item (c) listed in the definition of NSP.
MARKETING AND PROMOTION OF THE PRODUCT. No later than January 2002 the Parties shall establish a Marketing Committee consisting of at least one representative from each Party who shall act as liaison between the Parties to ensure that Elan is up to date on the prevailing market conditions and Par's efforts at marketing and selling the Product. Within 90 days of the Regulatory Filing in the Territory with respect to the Product, Par will outline to Elan the structure of the promotional activities to be carried out by Par for the period up to the First Commercial Sale of the Product and for a period of I year thereafter. Par shall both prior to and subsequent to the launch of the Product communicate with Elan regarding its objectives for and performance of such Product in the Territory. At such meetings, Par shall report on the ongoing sales performance of the Product in the Territory, including marketing approaches, educational campaigns, promotional and advertising materials and campaigns, sales plans and results, performance against competitors, its objectives for the Product and its plans for the next year of the Agreement. In addition the Marketing Committee shall review the quarterly royalty statements.
MARKETING AND PROMOTION OF THE PRODUCT. 10.1. No later than January 2002 the Parties shall establish a Marketing Committee consisting of at least one representative from each Party who shall act as liaison between the Parties to ensure that Elan is up to date on the prevailing market conditions and Par's efforts at marketing and selling the Products. 10.2. Within 90 days of the filing of the Regulatory Application in the Territory with respect to each Product, Par will outline to Elan the structure of the promotional activities to be carried out by Par for the period up to the First Commercial Sale of the Product and annually thereafter. 10.3. Par shall both prior to and subsequent to the launch of the Product communicate with Elan at meetings of the Marketing Committee regarding its objectives for and performance of such Product in the Territory. At such meetings, Par shall report on the ongoing sales performance of the Product in the Territory, including marketing approaches, educational campaigns, promotional and advertising materials and campaigns, sales plans and results, performance against competitors, its objectives for the Product and its plans for the next year of the Agreement. In addition the Marketing Committee shall review the quarterly royalty statements. 10.4. Unless otherwise agreed by the Parties, the Marketing Committee shall meet at least once each calendar quarter, such meetings to continue until 2 years after launch of the last Product or such later time as may be agreed. Thereafter, the Parties shall meet on an annual basis. The Marketing Committee shall meet alternately at the offices of Elan and Par or as otherwise agreed by the Parties. Each Party shall bear the cost of its own travel expenses. 10.5. Par shall control and shall be responsible for all decisions regarding the pricing policies and strategies with respect to the marketing and sales of each Product. Par shall control the format of the promotional campaign to be submitted to the FDA, but shall inform Elan thereof and provide to Elan a copy of each such promotional material for submission, at latest concurrent with its submission to the FDA. Par shall use reasonable efforts to obtain approval by the FDA of the promotional campaign for each Product and will provide to Elan any FDA correspondence thereto. 10.6. Par shall use reasonable commercial efforts consistent with its normal business practices to market and promote each Product throughout the Territory to all appropriate classes of trade and in doing so, s...
MARKETING AND PROMOTION OF THE PRODUCT. LIGAND shall control and be responsible for the content and format of any PRODUCT promotional campaign submitted to the FDA.
MARKETING AND PROMOTION OF THE PRODUCT. No later than 30th June 1998, the Parties shall establish a MARKETING COMMITTEE consisting of at least one representative from each Party who shall act as liaison between the Parties to ensure that ELAN is up to date on the prevailing market conditions and SCHEIN's efforts at marketing and selling the PRODUCTS. Within 90 days of the REGULATORY FILING in the TERRITORY with respect to a Product, SCHEIN will outline to ELAN the structure of the promotional activities to be carried out by SCHEIN for the period up to the First Commercial Sale of the PRODUCT and for a period of 1 year thereafter. SCHEIN shall both prior to and subsequent to the launch of a PRODUCT communicate with ELAN regarding its objectives for and performance of such PRODUCT in the TERRITORY. At such meetings, SCHEIN shall report on the ongoing sales performance of the PRODUCTS in the TERRITORY, including marketing approaches, educational campaigns, promotional and advertising materials and campaigns, sales plans and results, performance against competitors, its objectives for the PRODUCTS and its plans for the next year of the Agreement. In addition the MARKETING COMMITTEE shall review the quarterly royalty statements and in particular the deductible items (c)and (d) listed in the definition of NSP.
AutoNDA by SimpleDocs
MARKETING AND PROMOTION OF THE PRODUCT. 8.1 Medicis shall have sole responsibility to determine first Commercial Sales timing and dates in the Territory, provided however that Medicis shall perform or have performed the first Commercial Sale of the Current Product and any agreed future formulations of the Product, in each country of the Territory in which the first corresponding Regulatory Approval is granted without delay after the grant of such Regulatory Approval, but no later than three (3) months after such Regulatory Approval has been obtained; provided that Ipsen shall have made available sufficient supplies of such Product for Commercial Sales to commence. 8.2 Medicis will have sole responsibility for establishing the Product pricing for use in the Field, subject to applicable government regulations. 8.3 Medicis shall promote, distribute and sell the Product in the Territory through its established distribution systems as appearing in Appendix 6 hereto and/or through other Affiliates and/or Third Parties in accordance with the provisions of Article 2.2 above. 8.4 Medicis shall use its best endeavors comparable to the manner Medicis applies to its own leading aesthetic products in the Field in the Territory, or if not applicable, in other therapeutic or commercial areas, to promote, distribute and sell the Product in the Territory. 8.5 Medicis shall commit to a high level of quality and scientific excellence in its marketing, promotion and distribution of the Product in the Territory consistent with Medicis's highest standard of quality and scientific excellence. To that end, Medicis shall make sure that the sales representatives used by Medicis or any of Medicis's Affiliates, distributors or Third Party contractors are well trained in order to maintain a high level of quality and scientific excellence in all marketing activities. Medicis will use commercially reasonable efforts to provide Field Customers included in the Medicis Customer Base with technical support, training with the Product and instructions for use of the Product, in a manner consistent with Medicis's current practices in the provision of such support to its present customer base for its hyaluronic acid-based products. 8.6 Medicis shall promote the Products only within the Field and solely to Field Customers located in the Territory, to the exclusion of any contacts with or promotional visits to health professionals who do not pertain to the Field Customers; however, Medicis's marketing and promotion over the internet, r...
MARKETING AND PROMOTION OF THE PRODUCT 

Related to MARKETING AND PROMOTION OF THE PRODUCT

  • Marketing and Promotion The School will be responsible for marketing and promoting the Sports Facilities in accordance with the agreed aims and targets. A marketing strategy will be prepared and implemented and reviewed on an annual basis.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Training and Promotion a. The contractor will assist in locating, qualifying, and increasing the skills of minorities and women who are applicants for employment or current employees. Such efforts should be aimed at developing full journey level status employees in the type of trade or job classification involved. b. Consistent with the contractor's work force requirements and as permissible under Federal and State regulations, the contractor shall make full use of training programs, i.e., apprenticeship, and on-the-job training programs for the geographical area of contract performance. In the event a special provision for training is provided under this contract, this subparagraph will be superseded as indicated in the special provision. The contracting agency may reserve training positions for persons who receive welfare assistance in accordance with 23 U.S.C. 140(a). c. The contractor will advise employees and applicants for employment of available training programs and entrance requirements for each. d. The contractor will periodically review the training and promotion potential of employees who are minorities and women and will encourage eligible employees to apply for such training and promotion.

  • Advertising and Promotional Materials The Purchaser acknowledges and agrees that the Vendor shall have the right to use drawings, photographs, videos or other depictions of the interior and/or exterior of the Dwelling and/or the Subdivision or any components or features thereof in any promotional or advertising materials without notice to or consent from the Purchaser being required in any manner whatsoever.

  • Advertising and Promotion Al. ARTIST is to receive 100% star billing on all publicity releases and paid advertisement including - without limitations - programs, electronic media, flyers, signage, newspaper advertisements, marquees, tickets, radio spots, TV spots, etc. unless otherwise authorized in writing by PRODUCER. Billing on all advertising and publicity materials must appear as follows: A2. PURCHASER agrees to use only artwork, ad mats, photos and/or promotional materials provided or approved by PRODUCER. Publicity photos, bios and other assets can be downloaded from xxx.xxxxxxxx.xxx/xxxxxxxxxxxxxx PURCHASER shall supply all publicity and marketing materials to PRODUCER for review and approval prior to PURCHASER’s print deadlines and/or online launches.

  • Product Labeling The labeling of all Licensed Products sold or offered for sale under this Agreement shall expressly state that the Licensed Product is manufactured under a license from the Medicines Patent Pool.

  • Packaging and Labeling Seller shall properly xxxx, xxxx, and ship Goods and provide Buyer with shipment documentation showing the Order number, Seller’s identification number for the subject Goods, the quantity of goods in shipment and the number of cartons or containers in the shipment.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!